Affiliation:
1. Dr. Huang is a plastic surgeon in private practice in Thousand Oaks, California
2. Mr. Wichmann is a student at Goethe Medical School, Frankfurt, Germany
3. Dr. Mills is Clinical Assistant Professor, Department of Plastic Surgery, Loma Linda University, Loma Linda, California
Abstract
AbstractBackgroundTransaxillary subpectoral augmentation mammaplasty (TASPA) is not widely accepted due to perceived limitations in pocket access, visualization, control, and subsequent risk for postoperative complications. Current published data do little to substantiate or refute those claims.ObjectiveA retrospective chart review of a single surgeon’s 20-year experience with the TASPA technique was undertaken to assess the incidence of total secondary procedures, implant-related revisions, and reoperations unrelated to the implant.MethodsThe senior author (DCM) performed 1776 primary TASPA procedures from January 1989 through December 2008. Of those, 94 patients did not meet inclusion criteria, leaving a total of 1682 records for analysis. Data reviewed included age, date of surgery, race, implant size and type, manufacturer, and reasons for reoperation.ResultsAverage age was 32.7 ± 8.1 years (range, 16-62). Average implant size was 438.5 ± 51.5 cc (range, 270-630). Implants from Allergan/Inamed/McGhan (Irvine, CA), Dow-Corning (Midland, MI), Mentor (Santa Barbara, CA), and Surgitek (Racine, PA) were inserted (n = 2094 saline, n = 1270 silicone). Mean follow-up time was 37.9 ± 45.4 months (range, one month to 19.8 years). Excluding staged mastopexies and treatment for breast cancer, total secondary procedures were required in 225 patients (13.4%). Implant-related revisions included malposition (2.97%), size change (2.5%), and capsular contracture (1.9%). Perioperatively, no infections occurred, and two patients (0.12%) experienced hematoma. Most reoperations (62.8%) were performed through the axilla. Comparison to published data showed an equal or lower rate of capsular contracture, hematoma, and infection with the TASPA approach.ConclusionsGiven its advantages of an inconspicuous scar, decreased infection, and decreased capsular contracture, TASPA can be safely offered to patients as an option in breast augmentation.
Publisher
Oxford University Press (OUP)
Reference72 articles.
1. Implantation des prostheses mammaires par incision axillaire;Troques;Nouv Presse Med,1972
2. Breast augmentation: the axillary approach;Hoehler;Br J Plast Surg,1973
3. Transaxillary subpectoral augmentation mammaplasty;Peterson
4. Axillary subpectoral mammaplasty;Noonan
5. Subpectoral transaxillary method of breast augmentation in Orientals;Watanabe;Aesthetic Plast Surg,1982
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献